Abstract
This study aimed to investigate whether paraoxonase 1 (PON1) Q192R and L55M polymorphisms are associated with susceptibility to amyotrophic lateral sclerosis (ALS). We conducted a meta-analysis of the associations between the PON1 Q192R and L55M polymorphisms and ALS. A total of 2,831 patients and 3,123 controls from eight studies of the PON1 Q192R polymorphism and seven studies of the PON1 L55M T polymorphism were considered for this study. Meta-analysis showed no association between ALS and the PON1 192R allele (OR = 1.052, 95 % CI = 0.923–1.207, p = 0.447), and the PON1 55M allele (OR = 1.015, 95 % CI = 0.884–1.164, p = 0.837) in all study subjects. Similarly, no association was found between ALS and the PON1 Q192R and L55M polymorphisms using recessive, dominant or homozygote contrast models. Stratification by ethnicity indicated no association between ALS and the PON1 192R allele (OR = 1.058, 95 % CI = 0.910–1.231, p = 0.464) and the PON1 55M allele (OR = 1.027, 95 % CI = 0.889–1.185, p = 0.721) in the European population. This meta-analysis showed lack of associations between PON1 Q192R and L55M polymorphisms and susceptibility to ALS in the European population.
Similar content being viewed by others
References
Monk PN, Shaw PJ (2006) ALS: life and death in a bad neighborhood. Nat Med 12(8):885–887
Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8(1):28
Schymick JC, Talbot K, Traynor BJ (2007) Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 16:R233–R242
Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180(2):242–247
Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D et al (2006) Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler 7(3):173–182
Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C et al (2003) The DNA sequence of human chromosome 7. Nature 424(6945):157–164
Scacchi R, Corbo RM, Rickards O, De Stefano GF (2003) New data on the world distribution of paraoxonase (PON1 Gln 192→Arg) gene frequencies. Hum Biol 75(3):365–373
Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14(3):334–336
Chen Y, Huang R, Chen K, Song W, Yang Y, Zhao B et al (2012) Association analysis of PON polymorphisms in sporadic ALS in a Chinese populationl. Neurobiol Aging 33(12):2949e1
Ricci C, Battistini S, Cozzi L, Benigni M, Origone P, Verriello L et al (2011) Lack of association of PON polymorphisms with sporadic ALS in an Italian population. Neurobiol Aging 32(3):552
Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME et al (2008) Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 70(12):929–934
Cronin S, Greenway MJ, Prehn JH, Hardiman O (2007) Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78(9):984–986
Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT et al (2006) Paraoxonase gene polymorphisms and sporadic ALS. Neurology 67(5):766–770
Landers JE, Shi L, Cho TJ, Glass JD, Shaw CE, Leigh PN et al (2008) A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler 9(5):306–314
Morahan JM, Yu B, Trent RJ, Pamphlett R (2007) Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet B Neuropsychiatr Genet 144B(7):885–890
Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK et al (2007) Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 130(Pt 9):2292–2301
Morahan JM, Yu B, Trent RJ, Pamphlett R (2007) A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 28(3):532–540
Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118(2):225–234
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27(2):157–161
Lee YH, Witte T, Momot T, Schmidt RE, Kaufman KM, Harley JB et al (2005) The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 52(12):3966–3974
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Chapuis J, Boscher M, Bensemain F, Cottel D, Amouyel P, Lambert JC (2009) Association study of the paraoxonase 1 gene with the risk of developing Alzheimer’s disease. Neurobiol Aging 30(1):152–156
Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM et al (2009) A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 73(1):16–24
Acknowledgments
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, Y.H., Kim, JH., Seo, Y.H. et al. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Neurol Sci 36, 11–20 (2015). https://doi.org/10.1007/s10072-014-1979-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-014-1979-y